Pharmaceutical Industry Information Portal

Production of one of the world’s most sought-after drugs for migraine therapy starts in Moscow

The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.

GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg

On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.

GEROPHARM will localize the production of 300 IU/mL insulin glargine in Kazakhstan

On June 8, at the Eurasia – Our Home exhibition, GEROPHARM and Karaganda Pharmaceutical Plant signed a long-term contract...

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

Radiopharmaceuticals Production Complex Built by Rosatom Starts Medical Supplies to Bolivian clinics

A unique for Latin America complex for radiopharmaceuticals production buit by Rosatom by order of the Bolivian Nuclear Energy...

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin,...

Amgen sells its Turkish manufacturing arm for $135M

Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

GMP-inspections of veterinary manufacturers in the fourth quarter of 2023

This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP) which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").

GMP-inspections of veterinary manufacturers in the third quarter of 2023

This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the GMP Rules requirements which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").

GMP-inspections of veterinary manufacturers in the second quarter of 2023

There are only two months left before the amendments to Federal Law No. 61-FZ of 12.04.2010 "On the Circulation...

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Pharmaceutical Drug Production in Russia (June, January–June 2023)

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.

RNC Pharma: Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.

RNC Pharma: Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).